Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Clinical trial NCT00499252 · COMPLETED

Trial details

NCT number: NCT00499252
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Recurrent Ovarian Carcinoma

Start date: 2007-06-01
Primary completion: 2011-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.